BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  Opexa Therapeutics Appoints Lorin J. Randall to Board of Directors

  September 20, 2007

   · 

  1 min read
• Pharm Country

  Hi-Tech Pharmacal to Present at the UBS Warburg Global Life Sciences Conference

  September 20, 2007

   · 

  1 min read
• Pharm Country

  Antigenics Inc. (New York) to Present at UBS Warburg Global Life Sciences Conference

  September 20, 2007

   · 

  1 min read
• Deals

  Shareholders Approve Inhibetex Therapeutics Inc. Acquisition of FermaVir Pharmaceuticals, Inc.

  September 20, 2007

   · 

  1 min read
• BioMidwest

  Eli Lilly and Company Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer

  September 20, 2007

   · 

  17 min read
• BioCapital

  Bavarian Nordic Strengthens Commercial Focus; Pipeline Update

  September 20, 2007

   · 

  3 min read
• Business

  Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease

  September 20, 2007

   · 

  3 min read
• Drug Development

  The International Myeloma Foundation Reports That Interim Findings from Global Trial Extend Positive Benefits of VELCADE to Newly Diagnosed Patients

  September 20, 2007

   · 

  1 min read
• Drug Development

  Medivir AB: MIV-701 Preclinical Efficacy Data Presented

  September 20, 2007

   · 

  1 min read
• BioMidwest

  AtriCure, Inc. to Present at 2007 UBS Warburg Global Life Sciences Conference

  September 20, 2007

   · 

  1 min read